William Garrett Gray
2020
In 2020, William Garrett Gray earned a total compensation of $677.5K as Chief Financial Officer, Corporate Secretary and Treasurer at Checkpoint Therapeutics, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $78,120 |
|---|---|
| Salary | $210,000 |
| Stock Awards | $381,510 |
| Other | $7,876 |
| Total | $677,506 |
Gray received $381.5K in stock awards, accounting for 56% of the total pay in 2020.
Gray also received $78.1K in non-equity incentive plan, $210K in salary and $7.9K in other compensation.
Rankings
In 2020, William Garrett Gray's compensation ranked 10,086th out of 13,090 executives tracked by ExecPay. In other words, Gray earned more than 22.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,086 out of 13,090 | 23rd |
Division Manufacturing | 4,329 out of 5,624 | 23rd |
Major group Chemicals And Allied Products | 1,784 out of 2,257 | 21st |
Industry group Drugs | 1,561 out of 1,957 | 20th |
Industry Pharmaceutical Preparations | 1,151 out of 1,462 | 21st |
Source: SEC filing on April 30, 2021.
Gray's colleagues
We found one more compensation record of an executive who worked with William Garrett Gray at Checkpoint Therapeutics in 2020.
2020
James Oliviero
Checkpoint Therapeutics
Chief Executive Officer
News
Checkpoint Therapeutics CEO James Oliviero's 2021 pay stays at $2.3M
April 29, 2022
Checkpoint Therapeutics CEO James Oliviero's 2020 pay slips 1% to $2.3M
April 30, 2021
Checkpoint Therapeutics CEO James Oliviero's 2019 pay rises 8% to $2.3M
April 24, 2020
Checkpoint Therapeutics CEO James Oliviero's 2018 pay jumps 230% to $2.1M
April 30, 2019